Congresses

Titlesort descending Year
2020 Common Agricultural Policy in Spain. General Equilibrium Effects of an EU28 budget deal 2015
3D Structure and biochemical characterization of the aspartate transcarbamoylase domain of human CAD 2015
3D structure prediction and AFM morphology study of human FAD synthase (isoform 2) 2017
3D-footprint: a database for the structural analysis of protein-DNA complexes 2010
3rd Annual Conference, Panel on Parliaments and Parliamentarians in Regional Integrations 2008
3rd Annual Conference, Panel on The EU as an International Player 2008
3rd Pan-hellenic Conference on IPE: The International Economy in the 21th Century: Towards Globalization or Regionalization? 2008
: Activación selectiva de las rutas de apoptosis por la granzima A y/o la granzima B en la lisis celular mediada por los CTL 2004
: comentarista del Grupo de Trabajo cobre Diplomacia(s) Pluaral(es) y copresentador de ponencia El Parlamento Europeo y el Conflicto en Venezuela (con Dra. Paula Lamoso González, Universidad Loyola Andalucía) 2021
: granzyme a and b of mouse cytotoxic t cells cleave cytoplasmic and plasma gelsolin: consequences for cell morphology inflammatory responses 2009
: In vivo elimination of drug-resistant tumor cells by cytotoxic T cells through a perforin/granzyme B-dependent mechanism 2012
: Inflamación inducida por células T citotoxicas y NK 2013
A BICISTRONIC RECOMBINANT ADENOVIRUS CARRYING BOTH P53 AND P16 TUMOR SUPPRESSO GENES FOR TREATMENT OF P53-RESISTANT GLIOMAS. 1998
a bright source of chiral quantum light 2012
a bright source of chiral quantum light 2012
A common signalosome for programmed cell death in humans and plants 2014
A comparative study of methodologies to encapsulate gold nanoparticles into exosomes for theragnostics 2018
A comparison of two different Rn-222 measurement methods in contrasting environments: high mountain site and Mediterranean coast 2011
A conservative interaction between cytochrome c and 14-3-3 proteins in programmed cell-death 2016
A design strategy that minimizes the susceptibility of HIV-1 protease inhibitors to mutations causing drug resistance 2002

Pages